Published in Biotech Business Week, May 4th, 2006
Although these companies have always recognized the need to collaborate with universities, the rise of molecular genetics since the 1980s and the consequent increasing complexity of drug discovery and development have driven the recent flourishing of such alliances. Academic-pharma alliances now fit many models, from a private consulting relationship between two individuals to large institutional partnerships, according to a report by Research and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.